Founder and CEO of Sigrid Therapeutics AB, recognized among the Top 10 Under 40 by Genetic Engineering News and Biospace, and named one of Sweden’s 101 Super Talents.
Sigrid is developing its patented SiPore® technology, offering a novel, drug-free approach to regulating metabolic diseases.
Prior to founding Sigrid, she worked in venture capital and business development, collaborating with leading global biopharmaceutical companies.
Copyright: © Sarajevo Slush'D All Rights Reserved
